WATERTOWN, Mass.--(BUSINESS WIRE)--Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, today published research in mBio, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback